ALC|Alcon AG|Price:63.795|Chg%:1.77

More Details of Alcon AG Company

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

Alcon AG Info



Ticker SymbolALC

Company nameAlcon AG

IPO dateApr 09, 2019

CEOEndicott (David J)

Number of employees25599

Security typeOrdinary Share

Fiscal year-endApr 09

AddressRue Louis d'Affry 6

CityFRIBOURG

Stock exchangeNASDAQ OMX NASDAQ Basic NYSE

CountrySwitzerland

Postal code1700

Phone41589113800

Websitehttps://www.alcon.ch/

Ticker SymbolALC

IPO dateApr 09, 2019

CEOEndicott (David J)

Company Executives of Alcon AG



Name

Name/Position

Position

Shareholding

Change

Mr. David J. Endicott

Chief Executive Officer, Director

269.77K

+23.23%

Mr. Timothy C. (Tim) Stonesifer

Chief Financial Officer, Senior Vice President

140.55K

+4.49%

Mr. Rajkumar Narayanan

Senior Vice President, President - International

48.83K

--

Mr. Ian Bell

Chief Operating Officer, Senior Vice President

47.49K

+36.34%

Ms. Karen J. May, CPA

Independent Director

41.42K

+31.62%

Mr. Laurent Attias

Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)

21.91K

-3.22%

Mr. Scott Harlan Maw

Independent Director

18.84K

+8.38%

Ms. Ines Poeschel

Independent Director

13.81K

+12.53%

Ms. Lynn Dorsey Bleil

Independent Director

12.42K

+11.96%

Ms. Deborah Di Sanzo

Director

450.00

--

Name

Name/Position

Position

Shareholding

Change

Mr. David J. Endicott

Chief Executive Officer, Director

269.77K

+23.23%

Mr. Timothy C. (Tim) Stonesifer

Chief Financial Officer, Senior Vice President

140.55K

+4.49%

Mr. Rajkumar Narayanan

Senior Vice President, President - International

48.83K

--

Mr. Ian Bell

Chief Operating Officer, Senior Vice President

47.49K

+36.34%

Ms. Karen J. May, CPA

Independent Director

41.42K

+31.62%

Mr. Laurent Attias

Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)

21.91K

-3.22%

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

By BusinessUSD

Name

Revenue

Proportion

Consumables

3.03B

29.34%

Contact lenses

2.77B

26.84%

Ocular health

1.80B

17.42%

Implantables

1.78B

17.27%

Equipment/other

941.00M

9.12%

By RegionUSD

Name

Revenue

Proportion

United States

4.66B

45.13%

Other

4.41B

42.76%

Japan

609.00M

5.90%

China

570.00M

5.52%

Switzerland

71.00M

0.69%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Consumables

3.03B

29.34%

Contact lenses

2.77B

26.84%

Ocular health

1.80B

17.42%

Implantables

1.78B

17.27%

Equipment/other

941.00M

9.12%

Shareholding Stats

Updated: Sun, May 10

Shareholders

Shareholder Types

Shareholders

Proportion

BlackRock Advisors (UK) Limited

4.94%

Vanguard Capital Management, LLC

2.98%

Norges Bank Investment Management (NBIM)

2.41%

UBS Fund Management (Switzerland) AG

2.29%

Aristotle Capital Management, LLC

2.21%

Other

85.16%

Shareholders

Proportion

BlackRock Advisors (UK) Limited

4.94%

Vanguard Capital Management, LLC

2.98%

Norges Bank Investment Management (NBIM)

2.41%

UBS Fund Management (Switzerland) AG

2.29%

Aristotle Capital Management, LLC

2.21%

Other

85.16%

Shareholder Types

Shareholders

Proportion

Investment Advisor

29.42%

Investment Advisor/Hedge Fund

25.94%

Bank and Trust

4.44%

Hedge Fund

3.48%

Sovereign Wealth Fund

2.50%

Research Firm

1.75%

Pension Fund

1.68%

Individual Investor

0.17%

Insurance Company

0.09%

Other

30.53%

Institutional Shareholding



Updated: Wed, Apr 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q1

1696

347.13M

69.47%

-16.53M

2025Q4

1623

342.44M

72.26%

+507.76K

2025Q3

1664

342.40M

72.42%

-9.24M

2025Q2

1658

350.50M

70.82%

+3.47M

2025Q1

1649

340.47M

77.49%

-46.78M

2024Q4

1637

370.92M

68.31%

+36.10M

2024Q3

1614

334.31M

67.55%

+3.20M

2024Q2

1581

336.83M

74.41%

-28.77M

2024Q1

1567

336.16M

66.45%

+4.09M

2023Q4

1583

325.43M

67.42%

+1.37M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

BlackRock Advisors (UK) Limited

24.68M

4.94%

--

Dec 31, 2025

Norges Bank Investment Management (NBIM)

12.05M

2.41%

+706.67K

+6.23%

Dec 31, 2025

UBS Fund Management (Switzerland) AG

11.47M

2.29%

-68.71K

-0.60%

Jun 30, 2025

Aristotle Capital Management, LLC

11.07M

2.21%

+360.01K

+3.36%

Dec 31, 2025

Zürcher Kantonalbank (Asset Management)

8.49M

1.7%

-648.99K

-7.10%

Sep 30, 2025

AKO Capital LLP

7.69M

1.54%

-287.66K

-3.61%

Dec 31, 2025

Fidelity Management & Research Company LLC

7.33M

1.47%

-125.69K

-1.69%

Dec 31, 2025

Select Equity Group, L.P.

6.22M

1.24%

-509.38K

-7.57%

Dec 31, 2025

Walter Scott & Partners Ltd.

4.47M

0.9%

+4.32M

+2841.01%

Dec 31, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

Global X Aging Population ETF

2.36%

Franklin FTSE Switzerland ETF

2.28%

iShares MSCI Switzerland ETF

2.2%

First Trust Indxx Medical Devices ETF

2.06%

Running Oak Efficient Growth ETF

1.77%

Global X S&P Catholic Values Developed ex-US ETF

1.07%

JPMorgan BetaBuilders Europe ETF

0.59%

iShares Global Healthcare ETF

0.53%

ALPS O'Shares International Developed Quality Dividend ETF

0.45%

Wahed Dow Jones Islamic World ETF

0.44%

Global X Aging Population ETF

Proportion2.36%

Franklin FTSE Switzerland ETF

Proportion2.28%

iShares MSCI Switzerland ETF

Proportion2.2%

First Trust Indxx Medical Devices ETF

Proportion2.06%

Running Oak Efficient Growth ETF

Proportion1.77%

Global X S&P Catholic Values Developed ex-US ETF

Proportion1.07%

JPMorgan BetaBuilders Europe ETF

Proportion0.59%

iShares Global Healthcare ETF

Proportion0.53%

ALPS O'Shares International Developed Quality Dividend ETF

Proportion0.45%

Wahed Dow Jones Islamic World ETF

Proportion0.44%

Dividend



A total of 400.00M USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Feb 25, 2026

ALC.NB Final Cash Dividend of gross CHF 0.28 paid on May 07, 2026 going ex on May 06, 2026

May 06, 2026

May 07, 2026

May 05, 2026

Mar 01, 2022

ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022

May 04, 2022

May 05, 2022

May 03, 2022

Feb 24, 2021

ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021

May 05, 2021

May 06, 2021

May 04, 2021

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data